Theramex Enters Into an Exclusive Licensing Agreement With Radius Health Inc, to Commercialise ELADYNOS® ▼in the European Economic Area, the United Kingdom, Australia and Brazil
Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has entered into an exclusive licensing agreement with Radius Health, Inc., for the rights to commercialise ELADYNOS® (abaloparatide), a novel bone forming agent indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures.
Theramex will commercialise and distribute ELADYNOS® on an exclusive basis in the European Economic Area, the United Kingdom, Australia and Brazil.
“Theramex has again shown its commitment to women and the care and good management of bone health, by adding this important product to our Osteoporosis franchise. We are delighted to be entering into this partnership with Radius, building on our expanding portfolio and aligning missions to reduce fracture risks for many postmenopausal women suffering from osteoporosis.” - Rob Stewart, CEO of Theramex
“We are thrilled to have Theramex bring abaloparatide to postmenopausal women in Europe who could benefit from this impactful treatment. Our aligned, strategic vision of bringing effective solutions to the right patient gives us unwavering confidence in this partnership. We look forward to seeing the continued global expansion of abaloparatide to patients with osteoporosis worldwide.” - Scott Briggs, CEO of Radius
About Theramex
Theramex is a leading global speciality pharmaceutical company dedicated to women and their health. Theramex supports women at different stages of their lives by providing a broad portfolio of innovative and established brands covering contraception, fertility, menopause, and osteoporosis. Theramex’s commitment is to listen to and understand its patients, serve their needs and offer healthcare solutions to help improve their lives. Theramex’s vision is to be a lifetime partner for women and the healthcare professionals who treat them by providing patient-focused and effective solutions that care for and support women through different stages of their life.
www.theramex.com
About Radius
Radius is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health and oncology. Radius’ lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration in April 2017 for the treatment of postmenopausal women with osteoporosis at high risk for fracture, and in December 2022 for the treatment of men with osteoporosis at high risk for fracture.
ELADYNOS®(abaloparatide) injection was approved by the European Medicines Agency for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapies. This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines.
www.radiuspharm.com
FOR MEDIA AND INVESTORS ONLY
ELAD_HQ_PRESSR_009443 D.O.P 8/3/23
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230308005585/en/
Contact information
For further information about Theramex, please contact:
Katja Lundell, Senior Director, Global Head of Policy, Pricing and Communications.
Email: Katja.Lundell@Theramex.com
Phone : +44 203 962 5555
For further information about Radius please contact:
Sara Goldberg: Lead, Communications
Email: corporatecommunications@radiuspharm.com
Phone: +1 631 379 8374
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Riyadh to Host the First Edition of BIO Middle East10.9.2025 21:01:00 EEST | Press release
The Saudi Ministry of Health has announced the launch of the first edition of BIO Middle East, the region’s pioneering event dedicated entirely to biotechnology. The event will take place from May 11 to 13, 2026, co-locating with CPHI Middle East at the Riyadh Exhibition and Convention Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910348484/en/ Riyadh to Host the First Edition of BIO Middle East (Graphic: AETOSWire) A first of its kind for the region, the event reinforces the Kingdom’s leadership in this fast-growing sector and underscores its commitment to becoming a regional and global hub for pharmaceuticals and life sciences. As part of a global series of landmark BIO gatherings that bring together leaders, innovators, and investors from across the world, BIO Middle East will extend this world-class platform for partnership and innovation to the region for the very first time. The BIO Middle East exhibition a
SingleStore Announces Growth Buyout Led by Vector Capital10.9.2025 20:00:00 EEST | Press release
SingleStore, Inc. (“SingleStore” or the “Company”), the leading data platform for enterprise AI, today announced it has entered into an agreement with Vector Capital Management, L.P. (“Vector”), a private equity firm with a nearly three decade track record leading transformational investments in established technology businesses, in which Vector will lead a growth buyout of SingleStore. Raj Verma, SingleStore’s Chief Executive Officer, and the Company’s established management team, who together have decades of experience in leading fast-growth, AI-first enterprise technology companies, will continue to lead the business. Long-term SingleStore shareholders including Google Ventures, Dell Technologies Capital, IBM, and REV Venture Partners will remain as investors in SingleStore. Several Vector Capital limited partners such as Adams Street Partners, J.P. Morgan Asset Management, the External Investing Group (XIG) at Goldman Sachs Asset Management, Angeles Investments, Lexington Partners,
FIA President Mohammed Ben Sulayem Leads Fight Against Online Abuse, Bringing Global Leaders Together in Stockholm10.9.2025 19:22:00 EEST | Press release
The Fédération Internationale de l'Automobile (FIA), the global governing body for motorsport and the federation for mobility organisations worldwide, has welcomed industry experts and thought leaders to Stockholm, Sweden, for the second global United Against Online Abuse (UAOA) conference. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910299906/en/ FIA President and UAOA Founder, Mohammed Ben Sulayem, speaking at the second global United Against Online Abuse (UAOA) conference. Bringing together voices from the world of sport, politics, and social media, the coalition reaffirmed their collective commitment to combatting online abuse, welcoming new members and sharing knowledge, innovation, and tools to accelerate progress in tackling this digital threat. Joined by high-profile attendees united in UAOA’s mission of eradicating online hate and creating a safer digital environment, FIA President and UAOA Founder, Mohammed B
Verimatrix and Velocix Team Up to Fight CDN Piracy10.9.2025 18:45:00 EEST | Press release
Regulatory News: Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced a strategic collaboration with Velocix, the market’s premier carrier-grade CDN software provider, to help streaming providers combat piracy, boost paid video subscriptions, and cut CDN costs. This joint initiative provides streaming providers with the means to detect, deny, and prevent unsanctioned usage of CDN capacity by third parties. CDN leeching, where unauthorized users consume content directly from the network without paying for it, is a critical and costly challenge for video service providers. Verimatrix Streamkeeper™ Counterspy protects the client side, ensuring only legitimate users can access content, by providing string app authentication, protecting content keys, and safeguarding the token exchange. Velocix’s Carrier-Grade CDN and Video Analytics Platform bring powerful server-side features, including advanced tokenization sc
Home-Compostable ButterFresh ™ Parchment Marks New Step in ProAmpac’s Sustainability Journey10.9.2025 18:14:00 EEST | Press release
ProAmpac, a global leader in flexible packaging and material science, proudly announces that its ButterFresh Parchment has earned the OK compost HOME certificate by TÜV AUSTRIA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250910223002/en/ ProAmpac's ButterFresh Parchment has earned the OK compost HOME certificate by TÜV AUSTRIA. ButterFresh Parchment is a wax-free, PFAS non-intent printed butter wrap designed for compostability without compromising performance and runability during the packing step. This parchment protects butter, margarine, and other oil-based solid products with superior grease resistance and excellent dead-fold properties, locking in freshness and reducing air exposure. “Earning the OK compost HOME certificate by TÜV AUSTRIA underscores our commitment to delivering packaging solutions that combine performance, process efficiency, and environmental responsibility,” said Ray Recchia, global innovation ma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom